US stocks finished the week on a positive note after a bruising two-day retreat following a dismal US economic growth report.
Friday’s rally limited the losses, with the Dow Jones Industrial Average finally dipping 56.08 points (0.31 percent) for the week to 18,024.06 and the broad-based S&P 500 shedding 9.40 (0.44 percent) to 2,108.29.
The decline in the NASDAQ was deeper, with the tech-rich index dropping 86.7 (1.7 percent) to 5,005.39
Photo: AFP
In a week packed with major earnings, economic reports and a US Federal Reserve meeting, the most impactful news was Wednesday’s stunner that the US economy grew just 0.2 percent in the first quarter.
The dismal gross domestic product figure, reflecting in part the drag from exceptionally cold winter weather and the West Coast port strike, prompted soul-searching on Wall Street.
“What a disappointment to think the US economy barely grew at all in the first quarter with the fed funds rate at the zero bound for more than six years now,” Briefing.com analyst Patrick O’Hare said.
The GDP report was followed later on Wednesday by a Fed policy statement that said the slower growth was due “in part” to transitory factors and that the economy should resume expanding at a “moderate pace.”
The communique suggested the Fed still expects to begin a slow series of rate rises in the coming months, though probably not next month.
Wells Fargo Investment Institute senior global equity strategist Scott Wren said the market “had a little tough time processing” the GDP data.
However, after two days, investors shrugged off their fears.
“The market is feeling better that the Fed’s not going to do too much here and that the economy is going to move forward at a modest pace,” he said.
Other data last week was mixed. The US Conference Board’s index of consumer confidence fell sharply to 95.2 last month from 101.4 in March. Other reports showed a modest rise in consumer spending in March and sluggish growth in manufacturing activity last month. US auto sales picked up last month.
Companies have generally bested what were very low expectations ahead of first-quarter earnings season. Of the 347 companies in the S&P 500 that have reported, 238 have reported earnings ahead of expectations, while 76 have missed, with the rest coming in at levels forecast by analysts. Only 45 percent have beaten expectations for revenues, according to S&P Capital IQ.
Standouts this week included drug giant Merck (up 3.9 percent this week), which raised its full-year forecast after adjusted earnings per share in the first quarter came in at US$0.85, US$0.11 above forecasts.
The market also a cheered a sunny report from online travel site Expedia, which reported a 19 percent increase in gross bookings and a 14 percent gain in revenue, lifting the stock 7.9 percent on Friday. However, other technology stocks suffered double-digit declines following disappointing results. This group included LinkedIn, Twitter, Yelp and Stratasys, a 3D printing company.
In other corporate news, generic drugs company Mylan finished the week 2.9 percent lower after it balked at an unsolicited takeover campaign from rival Teva even as its own proposed acquisition of Perrigo was again rejected.
Perrigo and Teva both fell 3.4 percent. Applied Materials agreed with Tokyo Electric to abandon their nearly US$10 billion merger agreement, citing opposition from the US Department of Justice on antitrust grounds.
Starwood Hotels & Resorts Worldwide announced it hired investment bank Lazard to undertake a strategic review of the company to enhance shareholder value. The move sparked speculation that Starwood, which owns the Westin hotel chain, could be acquired.
Next week’s calendar includes a handful of major earnings reports, including from Disney and 21st Century Fox. The schedule also contains some important economic releases, including last month’s jobs report from the US Department of Labor.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained